{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:33:24Z","timestamp":1759412004825},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,6,19]],"date-time":"2013-06-19T00:00:00Z","timestamp":1371600000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The quadrivalent human papillomavirus vaccine has been provided in Australia through the National Human Papillomavirus Vaccination Program since April 2007. National registry data demonstrates good coverage of the vaccine, with 73% of school-aged girls having received all three doses. To evaluate the effectiveness of the program, we propose a two-pronged approach. In one (sub study A), the prevalence of the vaccine-targeted human papillomavirus genotypes in a population cohort is being estimated, and will be analysed in relation to vaccination status, cervical cytology screening status, demographic, social, behavioural, medical and clinical factors. In sub study B, the distribution of human papillomavirus genotypes detected in high grade cervical intraepithelial neoplastic lesions from vaccine eligible women is being assessed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods\/Design<\/jats:title>\n            <jats:p>Sub Study A involves the recruitment of 1569 women aged 18\u201325, residing in Victoria, Australia, through Facebook advertising. Women who are sexually active are being asked to provide a self-collected vaginal swab, collected at home and posted into the study centre, where human papillomavirus DNA detection and genotyping is performed. Participants also complete an online questionnaire regarding sexual history, experience with, knowledge of, and attitudes towards human papillomavirus, the human papillomavirus vaccine, and cervical screening.<\/jats:p>\n            <jats:p>Sub Study B will involve the collection of 500 cervical biopsies, positively identified as containing high grade cervical intraepithelial neoplastic lesions and\/or adenocarcinoma in situ. Five serial sections are being taken from each case: sections 1 and 5 are being assessed to confirm the presence of the high grade cervical intraepithelial neoplastic lesions or adenocarcinoma in situ; human papillomavirus genotyping is performed on sections 2 and 3; single lesions are excised from section 4 using laser capture microdissection to specifically define causality of a human papillomavirus genotyping of each specific lesion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>Australia is well placed to gain a clear and early insight into the effectiveness of the human papillomavirus vaccine in reducing the prevalence of human papillomavirus infection in young women, and any subsequent reduction in the prevalence of pre-cancerous cervical lesions, specifically high grade cervical intraepithelial neoplasia lesions, particularly of vaccine related types. The findings of a successful population based human papillomavirus program will have wide-reaching translational benefits across the globe.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-13-296","type":"journal-article","created":{"date-parts":[[2013,6,19]],"date-time":"2013-06-19T00:14:59Z","timestamp":1371600899000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study)"],"prefix":"10.1186","volume":"13","author":[{"given":"Elisa J","family":"Young","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepehr N","family":"Tabrizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia ML","family":"Brotherton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D","family":"Wark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Pyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Saville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C David","family":"Wrede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmin","family":"Jayasinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota M","family":"Gertig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Pitts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne M","family":"Garland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,19]]},"reference":[{"issue":"12","key":"4076_CR1","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010, 127 (12): 2893-2917. 10.1002\/ijc.25516.","journal-title":"Int J Cancer"},{"key":"4076_CR2","volume-title":"Cervical Screening in Australia 2009\u20132010, Cancer series no. 67","author":"Welfare AIoHa","year":"2012","unstructured":"Welfare AIoHa: Cervical Screening in Australia 2009\u20132010, Cancer series no. 67. 2012, Canberra: AIHW"},{"issue":"9509","key":"4076_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","volume":"367","author":"M Kyrgiou","year":"2006","unstructured":"Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E: Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet. 2006, 367 (9509): 489-498. 10.1016\/S0140-6736(06)68181-6.","journal-title":"Lancet"},{"issue":"4","key":"4076_CR4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1471-0528.2002.99023.x","volume":"109","author":"KE Rogstad","year":"2002","unstructured":"Rogstad KE: The psychological impact of abnormal cytology and colposcopy. BJOG. 2002, 109 (4): 364-368. 10.1111\/j.1471-0528.2002.99023.x.","journal-title":"BJOG"},{"issue":"17","key":"4076_CR5","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1001\/jama.291.17.2100","volume":"291","author":"L Sadler","year":"2004","unstructured":"Sadler L, Saftlas A, Wang W, Exeter M, Whittaker J, McCowan L: Treatment for cervical intraepithelial neoplasia and risk of preterm delivery. JAMA. 2004, 291 (17): 2100-2106. 10.1001\/jama.291.17.2100.","journal-title":"JAMA"},{"issue":"19","key":"4076_CR6","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1056\/NEJMoa061760","volume":"356","author":"SM Garland","year":"2007","unstructured":"Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, et al: Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007, 356 (19): 1928-1943. 10.1056\/NEJMoa061760.","journal-title":"N Engl J Med"},{"issue":"9574","key":"4076_CR7","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/S0140-6736(07)60777-6","volume":"369","author":"EA Joura","year":"2007","unstructured":"Joura EA, Leodolter S, Hernandez-Avila M, Wheeler CM, Perez G, Koutsky LA, Garland SM, Harper DM, Tang GW, Ferris DG, et al: Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet. 2007, 369 (9574): 1693-1702. 10.1016\/S0140-6736(07)60777-6.","journal-title":"Lancet"},{"issue":"Suppl 5","key":"4076_CR8","doi-asserted-by":"publisher","first-page":"F123","DOI":"10.1016\/j.vaccine.2012.04.108","volume":"30","author":"JT Schiller","year":"2012","unstructured":"Schiller JT, Castellsague X, Garland SM: A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine. 2012, 30 (Suppl 5): F123-F138.","journal-title":"Vaccine"},{"key":"4076_CR9","volume-title":"J Infect Dis","author":"S Tabrizi","year":"2012","unstructured":"Tabrizi S, Brotherton J, Kaldor JM, Skinner R, Cummins E, Liu B, Bateson D, McNamee K, Garefalakis M, Garland SM: Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis. 2012, in press"},{"issue":"1","key":"4076_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","volume":"88","author":"GM Clifford","year":"2003","unstructured":"Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S: Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer. 2003, 88 (1): 63-73. 10.1038\/sj.bjc.6600688.","journal-title":"Br J Cancer"},{"issue":"2","key":"4076_CR11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.vaccine.2007.10.057","volume":"26","author":"JM Brotherton","year":"2008","unstructured":"Brotherton JM: How much cervical cancer in Australia is vaccine preventable? A meta-analysis. Vaccine. 2008, 26 (2): 250-256. 10.1016\/j.vaccine.2007.10.057.","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"4076_CR12","first-page":"S3\/26","volume":"24","author":"G Clifford","year":"2006","unstructured":"Clifford G, Franceschi S, Diaz M, Munoz N, Villa LL: Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine. 2006, 24 (Suppl 3): S3\/26-34.","journal-title":"Vaccine"},{"issue":"7","key":"4076_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","volume":"7","author":"S De Sanjose","year":"2007","unstructured":"De Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, Bosch FX: Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007, 7 (7): 453-459. 10.1016\/S1473-3099(07)70158-5.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"4076_CR14","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/ijc.22527","volume":"121","author":"JS Smith","year":"2007","unstructured":"Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM: Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. International journal of cancer Journal international du cancer. 2007, 121 (3): 621-632. 10.1002\/ijc.22527.","journal-title":"International journal of cancer Journal international du cancer"},{"issue":"2","key":"4076_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1071\/SH10001","volume":"8","author":"DM Gertig","year":"2011","unstructured":"Gertig DM, Brotherton JM, Saville M: Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia. Sex Health. 2011, 8 (2): 171-178. 10.1071\/SH10001.","journal-title":"Sex Health"},{"issue":"9783","key":"4076_CR16","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/S0140-6736(11)60551-5","volume":"377","author":"JM Brotherton","year":"2011","unstructured":"Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM: Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet. 2011, 377 (9783): 2085-2092. 10.1016\/S0140-6736(11)60551-5.","journal-title":"Lancet"},{"issue":"7","key":"4076_CR17","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1136\/sextrans-2011-050234","volume":"87","author":"TR Read","year":"2011","unstructured":"Read TR, Hocking JS, Chen MY, Donovan B, Bradshaw CS, Fairley CK: The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect. 2011, 87 (7): 544-547. 10.1136\/sextrans-2011-050234.","journal-title":"Sex Transm Infect"},{"issue":"1","key":"4076_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1473-3099(10)70225-5","volume":"11","author":"B Donovan","year":"2011","unstructured":"Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, Wand H, Fairley CK: Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis. 2011, 11 (1): 39-44. 10.1016\/S1473-3099(10)70225-5.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"4076_CR19","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/sti.2009.037788","volume":"85","author":"CK Fairley","year":"2009","unstructured":"Fairley CK, Hocking JS, Gurrin LC, Chen MY, Donovan B, Bradshaw CS: Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women. Sex Transm Infect. 2009, 85 (7): 499-502. 10.1136\/sti.2009.037788.","journal-title":"Sex Transm Infect"},{"issue":"3","key":"4076_CR20","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1071\/SH09137","volume":"7","author":"JM Brotherton","year":"2010","unstructured":"Brotherton JM, Kaldor JM, Garland SM: Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy. Sex Health. 2010, 7 (3): 310-319. 10.1071\/SH09137.","journal-title":"Sex Health"},{"key":"4076_CR21","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1741-7015-9-104","volume":"9","author":"SM Garland","year":"2011","unstructured":"Garland SM, Brotherton JM, Condon JR, McIntyre PB, Stevens MP, Smith DW, Tabrizi SN: Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program. BMC Med. 2011, 9: 104-10.1186\/1741-7015-9-104.","journal-title":"BMC Med"},{"issue":"5","key":"4076_CR22","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.vaccine.2004.07.046","volume":"23","author":"SR Pagliusi","year":"2004","unstructured":"Pagliusi SR, Teresa Aguado M: Efficacy and other milestones for human papillomavirus vaccine introduction. Vaccine. 2004, 23 (5): 569-578. 10.1016\/j.vaccine.2004.07.046.","journal-title":"Vaccine"},{"issue":"1","key":"4076_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/AOG.0b013e31818f5008","volume":"113","author":"PE Castle","year":"2009","unstructured":"Castle PE, Schiffman M, Wheeler CM, Solomon D: Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol. 2009, 113 (1): 18-25.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"4076_CR24","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.2196\/jmir.1978","volume":"14","author":"Y Fenner","year":"2012","unstructured":"Fenner Y, Garland SM, Moore EE, Jayasinghe Y, Fletcher A, Tabrizi SN, Gunasekaran B, Wark JD: Web-based recruiting for health research using a social networking site: an exploratory study. J Med Internet Res. 2012, 14 (1): e20-10.2196\/jmir.1978.","journal-title":"J Med Internet Res"},{"issue":"6","key":"4076_CR25","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.canep.2009.10.013","volume":"33","author":"N Bhatla","year":"2009","unstructured":"Bhatla N, Dar L, Patro AR, Kumar P, Kriplani A, Gulati A, Iyer VK, Mathur SR, Sreenivas V, Shah KV, et al: Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?. Cancer Epidemiol. 2009, 33 (6): 446-450. 10.1016\/j.canep.2009.10.013.","journal-title":"Cancer Epidemiol"},{"issue":"5","key":"4076_CR26","first-page":"513","volume":"163","author":"JW Sellors","year":"2000","unstructured":"Sellors JW, Lorincz AT, Mahony JB, Mielzynska I, Lytwyn A, Roth P, Howard M, Chong S, Daya D, Chapman W, et al: Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. Cmaj. 2000, 163 (5): 513-518.","journal-title":"Cmaj"},{"issue":"6","key":"4076_CR27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/01.olq.0000240315.19652.59","volume":"34","author":"RL Winer","year":"2007","unstructured":"Winer RL, Feng Q, Hughes JP, Yu M, Kiviat NB, O'Reilly S, Koutsky LA: Concordance of self-collected and clinician-collected swab samples for detecting human papillomavirus DNA in women 18 to 32 years of age. Sex Transm Dis. 2007, 34 (6): 371-377.","journal-title":"Sex Transm Dis"},{"issue":"1","key":"4076_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/jama.283.1.81","volume":"283","author":"TC Wright Jr","year":"2000","unstructured":"Wright TC, Denny L, Kuhn L, Pollack A, Lorincz A: HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA. 2000, 283 (1): 81-86. 10.1001\/jama.283.1.81.","journal-title":"JAMA"},{"issue":"1","key":"4076_CR29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/JCM.38.1.357-361.2000","volume":"38","author":"PE Gravitt","year":"2000","unstructured":"Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ: Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000, 38 (1): 357-361.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"4076_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1046\/j.1525-1438.1996.06030193.x","volume":"6","author":"J Layton-Henry","year":"1996","unstructured":"Layton-Henry J, Scurry J, Planner R, Allen D, Sykes P, Garland S, Borg A, Tabrizi S: Cervical adenoid basal carcinoma, five cases and literature review. Int J Gynecol Cancer. 1996, 6 (3): 193-199. 10.1046\/j.1525-1438.1996.06030193.x.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"4076_CR31","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jviromet.2006.02.007","volume":"135","author":"MP Stevens","year":"2006","unstructured":"Stevens MP, Garland SM, Tabrizi SN: Human papillomavirus genotyping using a modified linear array detection protocol. J Virol Methods. 2006, 135 (1): 124-126. 10.1016\/j.jviromet.2006.02.007.","journal-title":"J Virol Methods"},{"issue":"11","key":"4076_CR32","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1128\/JCM.01169-08","volume":"46","author":"MP Stevens","year":"2008","unstructured":"Stevens MP, Garland SM, Tabrizi SN: Validation of an automated detection platform for use with the roche linear array human papillomavirus genotyping test. J Clin Microbiol. 2008, 46 (11): 3813-3816. 10.1128\/JCM.01169-08.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"4076_CR33","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1309\/MPERNJ0G62RECHCQ","volume":"123","author":"SN Tabrizi","year":"2005","unstructured":"Tabrizi SN, Stevens M, Chen S, Rudland E, Kornegay JR, Garland SM: Evaluation of a modified reverse line blot assay for detection and typing of human papillomavirus. Am J Clin Pathol. 2005, 123 (6): 896-899. 10.1309\/MPERNJ0G62RECHCQ.","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"4076_CR34","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jviromet.2007.09.018","volume":"147","author":"MP Stevens","year":"2008","unstructured":"Stevens MP, Garland SM, Tabrizi SN: Development and validation of a real-time PCR assay specifically detecting human papillomavirus 52 using the Roche LightCycler 480 system. J Virol Methods. 2008, 147 (2): 290-296. 10.1016\/j.jviromet.2007.09.018.","journal-title":"J Virol Methods"},{"issue":"5","key":"4076_CR35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1503\/cmaj.070948","volume":"177","author":"L Rambout","year":"2007","unstructured":"Rambout L, Hopkins L, Hutton B, Fergusson D: Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials. Cmaj. 2007, 177 (5): 469-479.","journal-title":"Cmaj"},{"key":"4076_CR36","unstructured":"National Cervical Screening Program Renewal: http:\/\/www.cancerscreening.gov.au\/internet\/screening\/publishing.nsf\/Content\/ncsp-renewal,"},{"key":"4076_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/sextrans-2012-050612","volume":"0","author":"B Gunasekaran","year":"2012","unstructured":"Gunasekaran B, Jayasinghe Y, Fenner Y, Moore EE, Wark JD, Fletcher A, Tabrizi SN, Garland SM: Knowledge of human papillomavirus and cervical cancer among young women recruited using a social networking site. Sex Transm Infect. 2012, 0: 1-3. 10.1136\/sextrans-2012-050612.","journal-title":"Sex Transm Infect"},{"key":"4076_CR38","volume-title":"Cancer Series. vol. no. 61","author":"Australian Institute of Health and Welfare","year":"2011","unstructured":"Australian Institute of Health and Welfare: Cervical screening in Australia 2008\u20132009. Cancer Series. vol. no. 61. 2011, Canberra: Australian Institute of Health and Welfare"},{"key":"4076_CR39","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S1470-2045(11)70287-X","volume":"13","author":"CM Wheeler","year":"2011","unstructured":"Wheeler CM, Castellsague X, Garland SM, Szarewski A, Paavonen J, Naud P, Salmeron J, Chow SN, Apter D, Kitchener H, et al: Cross-protective efficacy of HPV-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol. 2011, 13: 100-110.","journal-title":"Lancet Oncol"},{"issue":"12","key":"4076_CR40","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.4161\/hv.7.12.18282","volume":"7","author":"MH Einstein","year":"2011","unstructured":"Einstein MH, Baron M, Levin MJ, Chatterjee A, Fox B, Scholar S, Rosen J, Chakhtoura N, Lebacq M, van der Most R, et al: Comparison of the immunogenicity of the human papillomavirus (HPV)-16\/18 vaccine and the HPV-6\/11\/16\/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18\u201345 years. Hum Vaccin. 2011, 7 (12): 1359-1373. 10.4161\/hv.7.12.18282.","journal-title":"Hum Vaccin"},{"issue":"2","key":"4076_CR41","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ijc.20244","volume":"111","author":"N Munoz","year":"2004","unstructured":"Munoz N, Bosch FX, Castellsague X, Diaz M, De Sanjose S, Hammouda D, Shah KV, Meijer CJ: Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer. 2004, 111 (2): 278-285. 10.1002\/ijc.20244.","journal-title":"Int J Cancer"},{"issue":"3","key":"4076_CR42","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/ijc.22527","volume":"121","author":"JS Smith","year":"2007","unstructured":"Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM: Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007, 121 (3): 621-632. 10.1002\/ijc.22527.","journal-title":"Int J Cancer"},{"issue":"Suppl 1","key":"4076_CR43","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jcv.2004.10.021","volume":"32","author":"HU Bernard","year":"2005","unstructured":"Bernard HU: The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. J Clin Virol. 2005, 32 (Suppl 1): S1-S6.","journal-title":"J Clin Virol"},{"issue":"5","key":"4076_CR44","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1128\/jvi.69.5.3074-3083.1995","volume":"69","author":"SY Chan","year":"1995","unstructured":"Chan SY, Delius H, Halpern AL, Bernard HU: Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol. 1995, 69 (5): 3074-3083.","journal-title":"J Virol"},{"issue":"1\u20132","key":"4076_CR45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1386-6532(00)00127-X","volume":"19","author":"AL Halpern","year":"2000","unstructured":"Halpern AL: Comparison of papillomavirus and immunodeficiency virus evolutionary patterns in the context of a papillomavirus vaccine. J Clin Virol. 2000, 19 (1\u20132): 43-56.","journal-title":"J Clin Virol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-296.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-296\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-296.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T01:47:13Z","timestamp":1630547233000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,19]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["4076"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-296","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,19]]},"assertion":[{"value":"28 February 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"296"}}